One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of CD152 cell marker, also known as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), in a clinical specimen.